Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

GH response to GHRH plus arginine is impaired in lipoatrophic women with human immunodeficiency virus compared with controls.

Zirilli L, Orlando G, Carli F, Madeo B, Cocchi S, Diazzi C, Carani C, Guaraldi G, Rochira V.

Eur J Endocrinol. 2012 Mar;166(3):415-24. doi: 10.1530/EJE-11-0829. Epub 2011 Dec 21.

2.

Gender differences in GH response to GHRH+ARG in lipodystrophic patients with HIV: a key role for body fat distribution.

Brigante G, Diazzi C, Ansaloni A, Zirilli L, Orlando G, Guaraldi G, Rochira V.

Eur J Endocrinol. 2014 Apr 10;170(5):685-96. doi: 10.1530/EJE-13-0961. Print 2014 May.

3.

Growth hormone secretion among HIV infected patients: effects of gender, race and fat distribution.

Koutkia P, Eaton K, You SM, Breu J, Grinspoon S.

AIDS. 2006 Apr 4;20(6):855-62.

PMID:
16549969
4.

Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy.

Koutkia P, Meininger G, Canavan B, Breu J, Grinspoon S.

Am J Physiol Endocrinol Metab. 2004 Feb;286(2):E296-303. Epub 2003 Oct 14.

5.

Impaired growth hormone secretion correlates with visceral adiposity in highly active antiretroviral treated HIV-infected adolescents.

Viganò A, Mora S, Brambilla P, Schneider L, Merlo M, Monti LD, Manzoni P.

AIDS. 2003 Jul 4;17(10):1435-41.

PMID:
12824780
6.

The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index.

Corneli G, Di Somma C, Baldelli R, Rovere S, Gasco V, Croce CG, Grottoli S, Maccario M, Colao A, Lombardi G, Ghigo E, Camanni F, Aimaretti G.

Eur J Endocrinol. 2005 Aug;153(2):257-64.

7.

Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan.

Valetto MR, Bellone J, Baffoni C, Savio P, Aimaretti G, Gianotti L, Arvat E, Camanni F, Ghigo E.

Eur J Endocrinol. 1996 Nov;135(5):568-72.

PMID:
8980159
8.

GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.

Procopio M, Maccario M, Savio P, Valetto MR, Aimaretti G, Grottoli S, Oleandri SE, Baffoni C, Tassone F, Arvat E, Camanni F, Ghigo E.

Panminerva Med. 1998 Mar;40(1):13-7.

PMID:
9573747
9.

Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation.

Bondanelli M, Ambrosio MR, Margutti A, Boldrini P, Basaglia N, Franceschetti P, Zatelli MC, Degli Uberti EC.

Metabolism. 2002 Oct;51(10):1363-9.

PMID:
12370860
10.

Body fat excess and stimulated growth hormone levels in adult patients with Prader-Willi syndrome.

Grugni G, Crinò A, Bertocco P, Marzullo P.

Am J Med Genet A. 2009 Feb 15;149A(4):726-31. doi: 10.1002/ajmg.a.32713.

PMID:
19267411
11.

Body fat mass is a strong and negative predictor of peak stimulated growth hormone and bone mineral density in healthy adolescents during transition period.

Perotti M, Perra S, Saluzzi A, Grassi G, Pincelli AI.

Horm Metab Res. 2013 Sep;45(10):748-53. doi: 10.1055/s-0033-1347243. Epub 2013 Aug 2.

PMID:
23913118
12.

Further evidence of cholinergic impairment of the neuroendocrine control of the GH secretion in Down's syndrome.

Beccaria L, Marziani E, Manzoni P, Arvat E, Valetto MR, Gianotti L, Ghigo E, Chiumello G.

Dement Geriatr Cogn Disord. 1998 Mar-Apr;9(2):78-81.

PMID:
9524798
13.

Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.

Alvarez P, Isidro L, Leal-Cerro A, Casanueva FF, Dieguez C, Cordido F.

Clin Endocrinol (Oxf). 2002 Apr;56(4):487-92.

PMID:
11966741
14.

Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine.

Broglio F, Benso A, Gottero C, Vito LD, Aimaretti G, Fubini A, Arvat E, Bobbio M, Ghigo E.

Eur J Endocrinol. 2000 Feb;142(2):157-63.

15.

Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity.

Savastano S, Angrisani L, Di Somma C, Rota F, Savanelli MC, Cascella T, Orio F, Lombardi G, Colao A.

Obes Surg. 2010 Feb;20(2):211-20. doi: 10.1007/s11695-009-9926-3. Epub 2009 Jul 28.

PMID:
19636643
16.

Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.

Alvarez-Castro P, Isidro ML, Garcia-Buela J, Leal-Cerro A, Broglio F, Tassone F, Ghigo E, Dieguez C, Casanueva FF, Cordido F.

Clin Endocrinol (Oxf). 2004 Aug;61(2):250-5.

PMID:
15272922
17.

GH/GHRH axis in HIV lipodystrophy.

Stanley TL, Grinspoon SK.

Pituitary. 2009;12(2):143-52. doi: 10.1007/s11102-008-0092-8.

PMID:
18270841
18.

Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults.

Corneli G, Di Somma C, Prodam F, Bellone J, Bellone S, Gasco V, Baldelli R, Rovere S, Schneider HJ, Gargantini L, Gastaldi R, Ghizzoni L, Valle D, Salerno M, Colao A, Bona G, Ghigo E, Maghnie M, Aimaretti G.

Eur J Endocrinol. 2007 Dec;157(6):701-8.

19.

Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging.

Arvat E, Ceda GP, Di Vito L, Ramunni J, Gianotti L, Broglio F, Deghenghi R, Ghigo E.

Pituitary. 1998 Apr;1(1):51-8.

PMID:
11081183
20.

Discrepant results in the diagnosis of GH deficiency with the insulin-tolerance test and the GHRH plus arginine test in patients with traumatic brain injury.

Schneider HJ, Herrmann BL, Schneider M, Sievers C, Schaaf L, Stalla GK.

Eur J Endocrinol. 2006 Oct;155(4):553-7.

Items per page

Supplemental Content

Write to the Help Desk